Get the Stockscreener App
160.19
0.19%
0.30
After Hours:
160.19
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Aptargroup Inc stock is traded at $160.19, with a volume of 278.08K.
It is up +0.19% in the last 24 hours and up +4.57% over the past month.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
See More
Previous Close:
$159.89
Open:
$159.29
24h Volume:
278.08K
Relative Volume:
1.02
Market Cap:
$10.61B
Revenue:
$3.56B
Net Income/Loss:
$320.21M
P/E Ratio:
38.05
EPS:
4.21
Net Cash Flow:
$322.99M
1W Performance:
+2.71%
1M Performance:
+4.57%
6M Performance:
+11.33%
1Y Performance:
+28.11%
1-Day Range:
$158.93
$160.42
1-Week Range:
$155.87
$161.55
52-Week Range:
$120.36
$161.55
Aptargroup Inc Stock (ATR) Company Profile
Name
Aptargroup Inc
Sector
Industry
Phone
(815) 477-0424
Address
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-20 | Initiated | Seaport Global Securities | Neutral |
| Apr-27-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-25-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-04-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-26-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-08-19 | Initiated | Morgan Stanley | Overweight |
| Apr-05-19 | Reiterated | BofA/Merrill | Underperform |
| Feb-27-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-18-18 | Initiated | Jefferies | Hold |
| Dec-07-16 | Downgrade | BofA/Merrill | Buy → Underperform |
| Oct-13-16 | Initiated | Jefferies | Hold |
| Jan-05-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-02-15 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-15-15 | Upgrade | BofA/Merrill | Neutral → Buy |
| May-01-15 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Feb-19-13 | Reiterated | Deutsche Bank | Hold |
| Jan-08-13 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-10-12 | Downgrade | KeyBanc Capital Mkts | Buy → Hold |
| Apr-11-12 | Initiated | KeyBanc Capital Mkts | Buy |
| Jun-13-11 | Upgrade | KeyBanc Capital Mkts | Hold → Buy |
View All
Aptargroup Inc Stock (ATR) Latest News
Is AptarGroup, Inc.'s (NYSE:ATR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Simply Wall St
Aptar Beauty Exhibits at Luxe Pack Monaco 2024 - Aptar
AptarGroup Hits 52-Week High: What's Driving the Stock's Performance? - MSN
Sei Investments Co. Increases Stake in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
Wall Street SWOT: AptarGroup stock shows resilience amid packaging sector challenges - Investing.com
Aptar works with FDA on chemical-absorbing film, expands in New York - Plastics News
AptarGroup stock hits 52-week high at $158.84 amid robust growth - Investing.com Canada
AptarGroup stock hits 52-week high at $158.84 amid robust growth - Investing.com
AptarGroup stock hits 52-week high at $158.84 amid robust growth - Investing.com Australia
Discover the Aptar Asia Innovation Center - Aptar
AptarGroup, Inc. (NYSE:ATR) Stock Holdings Lifted by Ensign Peak Advisors Inc - MarketBeat
Aptar Earns Acceptance to FDA's Emerging Technology Program for N-Sorb Solution - Packaging Strategies
Dimensional Fund Advisors LP Buys 64,288 Shares of AptarGroup, Inc. (NYSE:ATR) - MarketBeat
Aptar Pharma Celebrates North America Capacity Expansion - Aptar
Aptar Pharma Celebrates North America Capacity Expansion - Business Wire
Aptar's N-Sorb accepted into FDA Emerging Technology Program - Investing.com India
AptarGroup, Inc. (NYSE:ATR) Stock Position Cut by Atlas FRM LLC - MarketBeat
AptarGroup, Inc. (NYSE:ATR) Shares Acquired by Magnetar Financial LLC - MarketBeat
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program - BioSpace
Aptar's N-Sorb accepted into FDA Emerging Technology Program - Investing.com
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program - Aptar
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program - Yahoo Finance
AE Wealth Management LLC Has $14.87 Million Holdings in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
Zacks Research Weighs in on AptarGroup, Inc.'s Q1 2025 Earnings (NYSE:ATR) - MarketBeat
Bridges Investment Management Inc. Buys 94,013 Shares of AptarGroup, Inc. (NYSE:ATR) - MarketBeat
Adherence Packaging Market Size Expected to Reach USD 2.05 Billion by 2033 - GlobeNewswire Inc.
Applied Therapeutics stock surges after FDA update - The Pharma Letter
Business News - LatestLY
APRE stock touches 52-week low at $2.86 amid market challenges - Investing.com
AssetCo (LON:ASTO) shareholders have endured a 79% loss from investing in the stock three years ago - Yahoo Finance
AACT stock soars to all-time high of $10.82 amid market optimism - Investing.com Canada
Anglo Pacific Group (TSE:APY) Trading Down 4.2% - Defense World
Ares Acquisition Co. II (NYSE:AACT) Sets New 1-Year High at $10.81 - Defense World
American Assets Trust (NYSE:AAT) Reaches New 1-Year High at $27.56 - Defense World
Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules - AccessWire
Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules - StockTitan
Aptiv PLC Inc. (APTV) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Takeover rumours boost Advanced Medical’s shares - Investors Chronicle
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug - Benzinga
AptarGroup, Inc. (NYSE:ATR) Short Interest Update - MarketBeat
Applied Therapeutics Shares Rise as Drug Continues with Priority Review - MarketWatch
Parallel Advisors LLC Raises Stake in AptarGroup, Inc. (NYSE:ATR) - Defense World
Final phase of Apiatse redevelopment project to begin in October - Modern Ghana
AptarGroup, Inc. (NYSE:ATR) Stock Holdings Raised by DekaBank Deutsche Girozentrale - MarketBeat
Aptiv Stock: Is APTV Underperforming The Consumer Cyclical Sector? - Barchart
APM close to delisting - Business News
Aptitude Software Advances Share Buyback Programme - TipRanks
APM Shareholders Greenlight Acquisition Deal - TipRanks
APM shareholders endorse low-ball takeover - The West Australian
Abdiel Capital Advisors LP buys $668k in Appian Corp stock - Investing.com
APB short selling suspended as share price falls - The Star Online
Aptargroup Inc Stock (ATR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):